Surgery remains the main chance for cure, but only if diagnosis comes in time
Colorectal, pancreatic, and stomach cancers account for majority of abdominal cancer deaths in Brazil, with pancreatic cancer being disproportionately lethal despite representing only 1% of diagnoses. Early detection dramatically improves survival rates—pancreatic cancer survival can triple when caught early—but Brazil lacks established population screening strategies for most abdominal cancers.
- 74,000 Brazilians die annually from six types of abdominal cancer
- Colorectal cancer: 23,539 deaths; pancreatic: 14,571; stomach: 14,363
- 80% of pancreatic cancer patients diagnosed in advanced stages with metastasis
- Pancreatic cancer survival can triple when caught early versus advanced stages
- 59,500 new abdominal cancer cases projected annually in Brazil through 2028
Six types of abdominal tumors kill approximately 74,000 Brazilians annually, with colorectal cancer leading at 23,539 deaths. Late diagnosis due to silent early symptoms remains the primary challenge for treatment and survival.
Every year in Brazil, roughly 74,000 people die from six types of cancer that grow in the organs of the abdomen. The numbers keep climbing. What makes these deaths particularly grim is not the diseases themselves, but the moment they are found—almost always too late, when surgery and other treatments have lost their power to save.
A surgeon named Felipe José Fernández Coimbra, who leads the World Society of Surgical Oncology, compiled data from Brazil's health ministry and sent it to CNN Brasil. The picture is stark. Colorectal cancer kills the most: 23,539 Brazilians a year. Pancreatic cancer follows with 14,571 deaths, and stomach cancer with 14,363. Three cancers, three different organs, three different ways the body can fail—but the pattern is the same. People arrive at the hospital when it is already too late.
The reason is embedded in how these cancers announce themselves. Early on, they whisper. A person loses weight without trying. They feel weak. Their belly aches in a way that could mean anything. These symptoms are so ordinary, so easily mistaken for something minor, that months pass before anyone thinks to look deeper. By then, the cancer has already spread. By then, the surgeon's knife—still the best tool we have—cannot help.
Coimbra put it plainly: surgery remains the main chance for a cure, but only if the diagnosis comes in time. Take pancreatic cancer. When doctors catch it early, survival rates can more than triple compared to what happens when the disease has already advanced. The same logic holds for the other digestive cancers. But here is the problem: Brazil has no reliable system for screening the population for most of these tumors. There is no organized way to find them before they find their victims. The health system waits for people to get sick enough to notice, and by then, it is often too late.
Pancreatic cancer illustrates the cruelty of this gap. It accounts for only 1 percent of all cancer diagnoses in Brazil, yet it causes 5 percent of cancer deaths. About 80 percent of patients learn they have the disease only when it has already metastasized—when it has broken free from the pancreas and colonized other organs. At that point, the odds have shifted decisively against them.
The six cancers that make up this toll are colorectal, pancreatic, stomach, liver, esophageal, and peritoneal. Globally, the numbers are even larger. The World Health Organization's cancer research agency reported that colorectal cancer caused more than 904,000 deaths worldwide in 2022. Liver cancer claimed about 758,000 lives. Stomach cancer took roughly 660,000. Pancreatic cancer killed around 467,000, and esophageal cancer approximately 445,000. These are among the world's deadliest malignancies, and they are rising.
The reasons are familiar and preventable. Poor diet. Lack of exercise. Alcohol. Smoking. Chronic infections. And the simple fact that people are living longer—cancer is, in many ways, a disease of age. Brazil's population is aging. The risk factors are everywhere. The National Cancer Institute estimates that between 2026 and 2028, Brazil will see roughly 59,500 new cases of abdominal cancer each year, concentrated in the stomach, pancreas, esophagus, and liver.
Coimbra's conclusion was measured but urgent. The country needs a higher level of clinical suspicion—doctors and patients alike must learn to recognize the warning signs earlier. The health system needs to be reorganized to shrink the time between the first symptoms and a diagnosis. Without screening programs, without faster pathways to detection, the death toll will continue to climb. The cancers will keep their silence, and the silence will keep its cost.
Notable Quotes
We are talking about tumors where surgery, when possible, remains the primary chance for cure, but it is only viable when diagnosis is made in time— Felipe José Fernández Coimbra, surgeon and secretary-general of the World Society of Surgical Oncology
The problem is that for most of these cancers, we still lack well-established population screening strategies, which requires a higher level of clinical suspicion and health system organization to reduce the time between first symptoms and diagnosis— Felipe José Fernández Coimbra
The Hearth Conversation Another angle on the story
Why does pancreatic cancer kill so disproportionately compared to how often it's diagnosed?
Because by the time someone realizes something is wrong, the cancer has already escaped the pancreas and spread to other organs. At that point, surgery can't contain it. Early detection would change everything—survival rates would triple—but we don't have a screening system to find it before symptoms appear.
What would an early screening system look like for these cancers?
That's the hard part. Colorectal cancer has colonoscopy, which works. But for pancreatic, stomach, and liver cancers, there's no simple, reliable test you can give to everyone. You'd need imaging, blood markers, maybe genetic screening for high-risk people. It's expensive and complex.
So the system is waiting for people to get sick?
Exactly. And by then, the symptoms are so vague—weight loss, fatigue, belly pain—that people often wait months before seeing a doctor. By the time a diagnosis is made, the cancer has had time to spread.
What role do lifestyle factors play in this?
They're significant. Poor diet, sedentary living, alcohol, smoking—these all increase risk. But even if someone does everything right, without screening, they still won't know they have cancer until it's advanced. The lifestyle factors set the stage; the lack of early detection seals the fate.
Is this a Brazil-specific problem?
No. These are among the world's deadliest cancers globally. But Brazil's aging population and the absence of organized screening programs make the problem more acute here. Other countries have better infrastructure for catching these cancers earlier.
What would change the numbers?
Two things: screening programs that can identify cancer before symptoms appear, and a health system fast enough to move from suspicion to diagnosis in weeks, not months. Right now, neither exists at scale.